Correlation Between HCW Biologics and Ikena Oncology

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and Ikena Oncology, you can compare the effects of market volatilities on HCW Biologics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Ikena Oncology.

Diversification Opportunities for HCW Biologics and Ikena Oncology

0.38

Correlation Coefficient

HCW Biologics  Ikena Oncology

Weak diversification

The 3 months correlation between HCW and Ikena is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of HCW Biologics i.e., HCW Biologics and Ikena Oncology go up and down completely randomly.

Pair Corralation between HCW Biologics and Ikena Oncology

Given the investment horizon of 90 days HCW Biologics is expected to generate 7.8 times more return on investment than Ikena Oncology. However, HCW Biologics is 7.8 times more volatile than Ikena Oncology. It trades about 0.02 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.09 per unit of risk. If you would invest  42.00  in HCW Biologics on December 27, 2024 and sell it today you would lose (11.83) from holding HCW Biologics or give up 28.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

HCW Biologics  vs.  Ikena Oncology

HCW Biologics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Ikena Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with HCW Biologics and Ikena Oncology

The main advantage of trading using opposite HCW Biologics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.

The idea behind HCW Biologics and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.